ClassID:

95397

C07D475/10 - CPC Classification

Classification description:

Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with an aromatic or hetero-aromatic ring directly attached in position 2

Recent Application in this class:
#1
20190321366
2019-10-24

Modulators of toll-like receptors

#2
20190002465
2019-01-03

COMPOUNDS AS MODULATORS OF ROR GAMMA

#3
20180298005
2018-10-18

Pteridine derivatives as modulators of ROR gamma

#4
20180085370
2018-03-29

Modulators of toll-like receptors

#5
20180022749
2018-01-25

COMPOUNDS AS MODULATORS OF ROR GAMMA

#6
20170281637
2017-10-05

Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors

#7
20170275288
2017-09-28

PTERIDINES USEFUL AS HCV INHIBITORS AND METHODS FOR THE PREPARATION THEREOF

#8
20160317543
2016-11-03

Spirocyclic hetercycle compounds useful as HIV integrase inhibitors

#9
20160159803
2016-06-09

Pteridines useful as HCV inhibitors and methods for the preparation thereof

#10
20160158238
2016-06-09

Pteridines useful as HCV inhibitors and methods for the preparation thereof

#11
20160074403
2016-03-17

Immune system modulators

#12
20160067258
2016-03-10

Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors

#13
20160015713
2016-01-21

Modulators of toll-like receptors

#14
20150291607
2015-10-15

Compounds as modulators of RORγ

#15
20140316132
2014-10-23

Modulators of toll-like receptors

#16
20140221646
2014-08-07

Immune system modulators

#17
20140135315
2014-05-15

Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors

#18
20140094468
2014-04-03

Pteridines useful as HCV inhibitors and methods for the preparation thereof

#19
20140079724
2014-03-20

Immune system modulators

#20
20120271045
2012-10-25

Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

#21
20120142673
2012-06-07

Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors

#22
20110124638
2011-05-26

Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors

#23
20100143301
2010-06-10

Modulators of toll-like receptors

#24
20090156595
2009-06-18

Pteridines useful as HCV inhibitors and methods for the preparation thereof

#25
20080081809
2008-04-03

Compounds

#26
20070293500
2007-12-20

QUINAZOLINE DERIVATIVES AS MEDICAMENTS

#27
20070032477
2007-02-08

Pteridine derivatives useful for making pharmaceutical compositions

#28
20070004721
2007-01-04

Pteridine derivatives for the treatment of septic shock and tnf-a-related diseases

#29
20060287314
2006-12-21

Immunosuppressive effects of pteridine derivatives

#30
20060189620
2006-08-24

Immunosuppressive effects of pteridine derivatives

#31
20050096333
2005-05-05

Quinazoline derivatives as medicaments